# HTL Biotechnology

位于法国布列塔尼(占地逾 64,000 m²)的 HTL Biotechnology 是药用级生物聚合物的全球领导者,沿无溶剂路线贯通发酵、提取与纯化,并于 2025 年 6 月 6 日投产新的无菌透明质酸生产线。

Source: https://cn.bioecon.ru/companies/htl-biotechnology/
Updated: 2026-06-28

- 国家: France

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | Montagu收购多数股权（2022年） | https://htlbiotech.com/wp-content/uploads/2024/01/20220208-htl-announces-montagu-as-new-investor.pdf |
| 产能 | 含四个独立的透明质酸与多核苷酸生产单元；借助HTL4装置，透明质酸产能提升至2.3倍 | https://htlbiotech.com/about-us/our-company/our-latest-investments/, https://htlbiotech.com/about-us/our-company/our-production-department/, https://htlbiotech.com/our-industrial-platform/ |
| 认证 | ISO 13485、ISO 14001及Halal认证 | https://htlbiotech.com/about-us/our-company/our-production-department/, https://htlbiotech.com/blog/excellence-in-quality-the-foundation-of-htl-biotechnologys-pharma-grade-biopolymers/, https://htlbiotech.com/wp-content/uploads/2024/12/htl-rapport-rse-2023-gb.pdf |
| 监管批准 | 基地定期接受FDA与ANSM检查；原料药生产符合cGMP第II部分。 | https://htlbiotech.com/about-us/our-company/our-production-department/ |
| 生产基地 | 位于法国布列塔尼Javené的历史基地（超过64,000平方米）；美国生产单元；波士顿在建生产单元 | https://htlbiotech.com/about-us/our-company/our-production-department/, https://htlbiotech.com/our-industrial-platform/, https://htlbiotech.com/wp-content/uploads/2024/12/htl-rapport-rse-2023-gb.pdf |
| 员工人数 | 全球约179至300名员工 [中等置信度] | https://htlbiotech.com/wp-content/uploads/2024/12/htl-rapport-rse-2023-gb.pdf |
| 营收 | 报告为营业额100M（2023年报告）、$27.8M（LinkedIn/CB Insights）或$44.2M（Growjo） [中等置信度] | https://htlbiotech.com/wp-content/uploads/2024/12/htl-rapport-rse-2023-gb.pdf, https://www.clodura.ai/directory/company/htl-biotechnology |

独立来源: clodura.ai

## 技术

- [生物合成透明质酸](https://cn.bioecon.ru/technology/biosynthetic-hyaluronic-acid/)
- [重组胶原蛋白与明胶](https://cn.bioecon.ru/technology/recombinant-collagen-gelatin/)